NCT01471613 - Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions

Spinal Cord Injury

Interventions

PROCEDURE

Conventional Treatment

Conventional treatment includes surgeries such as laminectomy, spinal decompression etc. and the medicine generally adapted to treat spinal cord injury

DRUG

Lithium Carbonate Tablet

250mg/tablet, administrated orally for 6 weeks.

BIOLOGICAL

Cord Blood Cell

Cord blood mononuclear cell, 6.4 million viable cells, are transplanted into spinal cord at upper and lower edges of the injured site

OTHER

Placebo

Placebo tablet, orally administration of placebo for 6 weeks

Trial Locations (1)

650032

Treating Center of Spinal Cord Injury, Chinese PLA Chengdu Army Kunming General Hospital, Kunming

All Listed Sponsors

collaborator

Chengdu PLA General Hospital

OTHER

collaborator

StemCyte, Inc.

INDUSTRY

lead

China Spinal Cord Injury Network

NETWORK